Back to Journals » Therapeutics and Clinical Risk Management » Volume 8
![](https://www.dovepress.com/cr_data/cache/journal_image/1/cope/thumb_100_1000_100.jpg)
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2348)
- Volume 20, 2024 (40)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 8, 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Interventions performed by community pharmacists in one Canadian province: a cross-sectional study
Young SW, Bishop LD, Conway A
Therapeutics and Clinical Risk Management 2012, 8:415-421
Published Date: 6 December 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Glucarpidase to combat toxic levels of methotrexate in patients
Green JM
Therapeutics and Clinical Risk Management 2012, 8:403-413
Published Date: 22 November 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Appropriateness of administration of nasogastric medication and preliminary intervention
Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q
Therapeutics and Clinical Risk Management 2012, 8:393-401
Published Date: 20 November 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Consequences of neurologic lesions assessed by Barthel Index after Botox® injection may be underestimated
Dionyssiotis Y, Kiourtidis D, Karvouni A, Kaliontzoglou A, Kliafas I
Therapeutics and Clinical Risk Management 2012, 8:385-391
Published Date: 19 October 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
Rizzardini G, Bonfanti P, Carenzi L, Coen M, Orlando G, Di Matteo S, Colombo GL
Therapeutics and Clinical Risk Management 2012, 8:377-384
Published Date: 17 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Extreme intrafamilial variability of Saudi brothers with primary hyperoxaluria type 1
Alfadhel M, Alhasan KA, Alotaibi M, Al Fakeeh K
Therapeutics and Clinical Risk Management 2012, 8:373-376
Published Date: 28 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear
Tasci C, Tapan S, Ozkaya S, Demirer E, Deniz O, Balkan A, Ozkan M, Inan I, Kurt I, Bilgic H
Therapeutics and Clinical Risk Management 2012, 8:369-372
Published Date: 27 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment options for postmenopausal osteoporosis
Walsh GM
Therapeutics and Clinical Risk Management 2012, 8:367-368
Published Date: 28 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
Corcia P, Gordon PH
Therapeutics and Clinical Risk Management 2012, 8:359-366
Published Date: 27 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The first case of cutaneous infection with Mycobacterium parascrofulaceum
Zong WK, Zhang XD, Wang HS, Xu XL, Wang QL, Tian WW, Jin YL, Wu QX, Tang MY
Therapeutics and Clinical Risk Management 2012, 8:353-358
Published Date: 15 August 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
Chen Y, Han F
Therapeutics and Clinical Risk Management 2012, 8:343-351
Published Date: 11 July 2012
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Training in peroral endoscopic myotomy (POEM) for esophageal achalasia
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/BGvK77ikTYU/1.jpg)
Eleftheriadis N, Inoue H, Ikeda H, Onimaru M, Yoshida A, Hosoya T, Maselli R, Kudo S
Therapeutics and Clinical Risk Management 2012, 8:329-342
Published Date: 23 July 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
Wiwanitkit V
Therapeutics and Clinical Risk Management 2012, 8:323-328
Published Date: 22 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
Bloomgren G, Sperling B, Cushing K, Wenten M
Therapeutics and Clinical Risk Management 2012, 8:313-321
Published Date: 20 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college
Upadhyaya P, Seth V, Moghe VV, Sharma M, Ahmed M
Therapeutics and Clinical Risk Management 2012, 8:307-312
Published Date: 19 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Anastasilakis AD, Toulis KA, Polyzos SA, Anastasilakis CD, Makras P
Therapeutics and Clinical Risk Management 2012, 8:295-306
Published Date: 19 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational study
Iwamoto J, Takada T, Sato Y, Matsumoto H
Therapeutics and Clinical Risk Management 2012, 8:287-293
Published Date: 20 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Difficult airway and difficult intubation in postintubation tracheal stenosis: a case report and literature review
Zarogoulidis P, Kontakiotis T, Tsakiridis K, Karanikas M, Simoglou C, Porpodis K, Mitrakas A, Esebidis A, Konoglou M, Katsikogiannis N, Zervas V, Aggelopoulou C, Mikroulis D, Zarogoulidis K
Therapeutics and Clinical Risk Management 2012, 8:279-286
Published Date: 27 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Duloxetine in the management of chronic musculoskeletal pain
Smith HS, Smith EJ, Smith BR
Therapeutics and Clinical Risk Management 2012, 8:267-277
Published Date: 19 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted approaches in the treatment of osteoporosis: differential mechanism of action of denosumab and clinical utility
Cavalli L, Brandi ML
Therapeutics and Clinical Risk Management 2012, 8:253-266
Published Date: 11 June 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Prevention and management of accidental foreign body ingestion and aspiration in orthodontic practice
Umesan UK, Chua KL, Balakrishnan P
Therapeutics and Clinical Risk Management 2012, 8:245-252
Published Date: 23 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pain management with morphine: variation in analgesic response secondary to genetic polymorphisms
Kapoor S
Therapeutics and Clinical Risk Management 2012, 8:243-244
Published Date: 21 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacological management of binge eating disorder: current and emerging treatment options
McElroy SL, Guerdjikova AI, Mori N, O’Melia AM
Therapeutics and Clinical Risk Management 2012, 8:219-241
Published Date: 8 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
Gudin JA
Therapeutics and Clinical Risk Management 2012, 8:209-217
Published Date: 1 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of gabapentin enacarbil XR in restless legs syndrome
Sivam S, Yee BJ
Therapeutics and Clinical Risk Management 2012, 8:201-208
Published Date: 1 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures
Iwamoto J , Sato Y, Uzawa M, Matsumoto H
Therapeutics and Clinical Risk Management 2012, 8:195-199
Published Date: 10 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Maximizing neuroprotection: where do we stand?
Kuffler DP
Therapeutics and Clinical Risk Management 2012, 8:185-194
Published Date: 10 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease
Michel S, Bigdeli AK, Beiras-Fernandez A, Schmitz C, Wolf M, Sodian R, Kaczmarek I
Therapeutics and Clinical Risk Management 2012, 8:181-183
Published Date: 11 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal management of giant cell arteritis and polymyalgia rheumatica
Charlton R
Therapeutics and Clinical Risk Management 2012, 8:173-179
Published Date: 5 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Measurement complexity of adherence to medication
Galato D, Schuelter-Trevisol F, Piovezan AP
Therapeutics and Clinical Risk Management 2012, 8:169-171
Published Date: 2 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases
Wood P
Therapeutics and Clinical Risk Management 2012, 8:157-167
Published Date: 2 April 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
Goodman JJ, Martin SI
Therapeutics and Clinical Risk Management 2012, 8:149-156
Published Date: 26 March 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
Werth S, Halbritter K, Beyer-Westendorf J
Therapeutics and Clinical Risk Management 2012, 8:139-147
Published Date: 23 March 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
Hooper CY, Smith WJ
Therapeutics and Clinical Risk Management 2012, 8:131-137
Published Date: 16 March 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ
Therapeutics and Clinical Risk Management 2012, 8:105-130
Published Date: 9 March 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ruxolitinib for the treatment of myelofibrosis: its clinical potential
Ostojic A, Vrhovac R, Verstovsek S
Therapeutics and Clinical Risk Management 2012, 8:95-103
Published Date: 1 March 2012
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
NIHSS and acute complications after anterior and posterior circulation strokes
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/8AQn-H4mZ8M/1.jpg)
Boone M, Chillon JM, Garcia PY, Canaple S, Lamy C, Godefroy O, Bugnicourt JM
Therapeutics and Clinical Risk Management 2012, 8:87-93
Published Date: 27 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
Hagihara M, Umemura T, Mori T, Mikamo H
Therapeutics and Clinical Risk Management 2012, 8:79-86
Published Date: 17 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Noninvasive radioelectric asymmetric conveyor brain stimulation treatment improves balance in individuals over 65 suffering from neurological diseases: pilot study
Fontani V, Rinaldi S, Castagna A, Margotti ML
Therapeutics and Clinical Risk Management 2012, 8:73-78
Published Date: 17 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Coronary artery disease in Africa and the Middle East
Almahmeed W, Arnaout MS, Chettaoui R, Ibrahim M, Kurdi MI, Taher MA, Mancia G
Therapeutics and Clinical Risk Management 2012, 8:65-72
Published Date: 16 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions
Saffari F, Jalilolghadr S, Esmailzadehha N, Azinfar P
Therapeutics and Clinical Risk Management 2012, 8:55-63
Published Date: 2 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
Witkiewitz K, Saville KA, Hamreus K
Therapeutics and Clinical Risk Management 2012, 8:45-53
Published Date: 1 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New treatment options for lupus – a focus on belimumab
Chiche L, Jourde N, Thomas G, Bardin N, Bornet C, Darque A, Mancini J
Therapeutics and Clinical Risk Management 2012, 8:33-43
Published Date: 26 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions
Zeller RS, Davidson J, Lee HM, Cavanaugh PF
Therapeutics and Clinical Risk Management 2012, 8:25-32
Published Date: 25 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions
Zeller RS, Lee HM, Cavanaugh PF, Davidson J
Therapeutics and Clinical Risk Management 2012, 8:15-23
Published Date: 25 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical utility of adjunctive retigabine in partial onset seizures in adults
Rejdak K, Luszczki JJ, Błaszczyk B, Chwedorowicz R, Czuczwar SJ
Therapeutics and Clinical Risk Management 2012, 8:7-14
Published Date: 20 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Aripiprazole in the acute and maintenance phase of bipolar I disorder
Zupancic M, Gonzalez ML
Therapeutics and Clinical Risk Management 2012, 8:1-6
Published Date: 12 January 2012